Header cover image
  • Investing Ideas
  • /
  • Australian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Australian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

1

0 new

High return on equity, past performance and sound balance sheet.

1 companies

Neuren Pharmaceuticals

Market Cap: AU$2.3b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$18.60

7D

-6.9%

1Y

36.7%